Cognitive impairment in patients with Parkinson's disease and optimization of its treatment

dc.contributor.author	Zokirov M.M
dc.contributor.author	Mukhammadjonov O
dc.date.accessioned	2026-01-01T20:39:56Z
dc.date.issued	2022-04-23
dc.description.abstract	Parkinson's disease is the most common neurodegenerative disease in the world, which requires a comprehensive study of this disease, as well as the prevention of its complications. The article discusses the impairment of the cognitive status of patients with Parkinson's disease using the MMSE and FAB test tests, as well as the effect of the drug memantine hydrochloride on the cognitive status.
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/esh/article/view/1119
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/65734
dc.language.iso	eng
dc.publisher	Genius Publishing Group
dc.relation	https://geniusjournals.org/index.php/esh/article/view/1119/997
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	Eurasian Scientific Herald; Vol. 7 (2022): ESH; 177-180
dc.source	2795-7365
dc.subject	Parkinson's disease
dc.subject	Parkinson's syndrome
dc.subject	cognitive status
dc.subject	memantine hydrochloride
dc.title	Cognitive impairment in patients with Parkinson's disease and optimization of its treatment
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: mm_2022_cognitive_impairment_in_patients_with_pa.pdf
item.page.filesection.size: 220 KB
item.page.filesection.format: Adobe Portable Document Format